CRGT (Cortigent, Inc.) Net Income

A lack of pricing power due to the FDA clinical testing phase limits current revenues for Cortigent, Inc. (CRGT). The company's net income on this chart reflects the results of elite neurostimulator engineers who are provided with the necessary research resources. However, the business relies on external contractors for chip assembly. The latest value is recorded as , which allows for an assessment of the issuer's long-term development vector.

Company Net Income: Cortigent Medical (CRGT) for 07/04/2022 - 10/30/2026

Financial and market metric breakdowns for cortigent.com (CRGT)

- stock value and consensus price forecast:
Market Price Cortigent|CRGT - Analyst Consensus Forecast
- business market valuation indicators:
Market Valuation CRGT|CRGT - Total Company Value
- company book value details:
Net Asset Value per Share Cortigent|CRGT - Company Book Value|Market Value to Book Value cortigent.com|CRGT - Cumulative Company Assets
- debt and liquidity details:
Aggregate Debt to Capital Cortigent, Inc.|CRGT - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Cortigent|CRGT - Company Aggregate Debts|Debt to Net Assets CRGT|CRGT - Company Long-Term Debts|Short-Term Debt Cortigent|Immediate Liquidity Ratio cortigent.com
- company profitability and valuation multiples indicators:
CRGT - Net Income
Fundamental valuation:CRGT (Cortigent Medical)

This indicator measures the net balance of funds after deducting all operating and tax expenses, allowing for an objective assessment of business viability as opposed to market expectations. By analyzing the company's financial performance history, an investor determines profit stability, which in the case of Cortigent, Inc. (CRGT) is supported by long-term demand for neural implant services, guaranteeing a steady inflow of capital.

Direct competitors

Company Net Income Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Net Profit|Net Income regencellbioscience.com (RGC)|Company Net Income Axsome Therapeutics, Inc. (AXSM)|ACAD - Company Net Income|Company Net Income Xenon Pharmaceuticals Inc XENE|Final Profit VKTX|SUPN: Net Income|catalystpharma.com - Profit After Payment of Taxes|DNLI: Net Profit|HRMY - Net Financial Result|BHVN (Biohaven Pharmaceutical) - Net Profit|AMLX - Annual Net Income|Net Profit TRVI|PRAX - Company Net Income|Company Net Income Anavex Life Sciences Corp. AVXL|CBLL: Company Profit|PRTA: Net Income|Alector, Inc. - Profit After Payment of Taxes|ANNX (Annexon, Inc.) - Net Income|Omeros - Final Profit|NGNE (Neurogene) - Net Profit|AC Immune S.A. (ACIU) - Net Financial Result|Company Net Income Voyager Pharma (VYGR)|Neumora Corp - Company Profit|Net Profit SCLX (Scilex Holding Company)|TVGN - Net Income|ACOG: Net Income|Net Financial Result cogrx.com CGTX|IKT: Net Profit|Net Income Cassava Pharma|Company Net Income Assertio Holdings|COYA: Final Profit|Net Profit VTGN|ovidrx.com (OVID) - Annual Net Income|Acumen Pharma - Net Income|Profit After Payment of Taxes CRVO (CervoMed Corporation)|ATHE - Company Net Income|CLNN (Clene Inc.) - Company Profit|PEPG: Net Profit|Company Net Income jupiterneurosciences.com (JUNS)|Net Income RLMD|Net Profit Annovis Bio Corporation|Company Net Income Grace Therapeutics, Inc. (GRCE)|AIFF (fireflyneuro.com) - Final Profit|Company Net Income Klotho Neurosciences KLTO|NeuroSense Therapeutics Ltd (NRSN) - Company Net Income|Reviva Pharmaceuticals Holdings - Net Profit|MetaVia Inc (MTVA) - Net Income|NeurAxis, Inc. (NRXS) - Company Net Income|Company Net Income Helius Medical Technologies (HSDT)|Company Net Income Passage Bio Inc.|NEUP: Final Profit|Net Income NERV (Minerva Neurosciences Corp)|Profit After Payment of Taxes ATHA|Net Profit ADXN (Addex Therapeutics)|Net Financial Result Alzamend Neuro Inc. (ALZN)|Cyclerion - Net Profit|Annual Net Income Protagenic Therapeutics (PTIX)|KTTA: Net Profit|Company Net Income Avenue Therapeutics Inc (ATXI)|Company Net Income Brainstorm Cell|Company Profit CARA (caratherapeutics.com)|Net Income CHRO (Chromocell Therapeutics Corp.)|Profit After Payment of Taxes ELYM|Intra-Cellular Therapies, Inc. - Net Income|Final Profit LBPH|Marinus Pharmaceuticals - Net Profit|Net Financial Result nkgenbiotech.com NKGN|NeuroBo Pharmaceuticals, Inc. (NRBO) - Company Net Income|Company Profit SAGE|SNPX (Neurotrope) - Net Profit|Net Income Trevena Inc (TRVN)|Net Income VIGL (Vigil Neuroscience)|Net Financial Result Anew Medical Inc.|Net Profit CERE (Cerevel Therapeutics, Inc.)